About NBR“Nightly Business Report produced by CNBC” (NBR) is an award-winning and highly-respected nightly business news program that airs on public television. Television’s longest-running evening business news broadcast, “NBR” features in-depth coverage and analysis of the biggest financial news stories of the day and access to some of the world’s top business leaders and policy makers.
- Jack Bogle’s 5 bold investment predictions for 2018 and beyond
- Here are some deductions that can reduce your 2017 tax bill
- 3-2-1, BOOM! Georgia Dome imploded in downtown Atlanta
- These are the top 10 best gift cards this season
- These cities have the best chance of snaring Amazon's new $5 billion headquarters
NBR on TwitterMy Tweets
Subscribe to RSS
Health insurer Aetna has hired Ben Wanamaker from Wal-Nart’s health division to lead its joint venture with Apple, according to a source.
The settlement came after an unusual lawsuit by Sanofi, a competitor to Mylan, which alleged anti-competitive tactics.
Goldman Sachs added biotech company Biogen to its Americas Conviction List, citing a ‘blockbuster’ drug.
This could result in a boon in sales for Apple’s health and fitness-tracking smartwatch.
Venture capitalist Jonathan Silverstein is using his problem-solving skills to find a cure for Parkinson’s.
Nurses and home-care aides at Libertana Home Health Care have been experimenting by using Alexa with some elderly clients.
Before the FDA’s approval, sickle cell patients most commonly were treated with a drug that’s also used in chemotherapy.
President Donald Trump is hoping to bring down drug costs and speed the FDA approval process.
The number of insurers applying to sell health plans next year on HealthCare.gov, the federal Obamacare marketplace, is down 38 percent.
Why aren’t more people actively looking for work again with the job market so strong? Part of the answer may be opioid addiction.
The CBO’s estimate of the plan’s effect on the number of uninsured Americans could influence whether Republican senators support it.
While the Senate bill leaves many of the ACA’s provisions in place, it does so with less generous funding.
With just one week left for insurers to submit rate requests for 2018, it is unclear whether Obamacare subsidies will be funded.
The fate of cost sharing reduction subsidies under the Obamacare exchanges remains unclear, leaving some concerned about the future of their health care options. Bertha Coombs reports.
Whatever gets decided is going to affect patients, health workers and the overall economy.